Glucose B.Braun (Glucose Monohydrate)

Glucose B.Braun is used in clinical settings where rapid elevation of blood glucose or provision of an energy source is required.

• Treatment of hypoglycemia when oral glucose is not feasible.
• Component of parenteral nutrition regimens for patients unable to eat or absorb nutrients enterally.
• Fluid replacement therapy to maintain intravascular volume and osmolar balance.
• Support of electrolyte balance during surgery or critical care.
• Adjunct in diagnostic procedures that require controlled glucose infusion.
• Provision of glucose during prolonged fasting or pre‑operative preparation.

Intravenous administration of Glucose B.Braun can be associated with a range of adverse reactions, most of which are mild and transient, while rare events may be serious.

Common

• Transient increase in blood glucose concentration that usually normalizes without intervention.
• Mild irritation, redness, or discomfort at the intravenous infusion site.
• Nausea, mild abdominal discomfort, or a feeling of fullness.
• Fluid overload manifested as peripheral edema in patients with limited cardiac reserve.

Serious

• Marked hyperglycemia that may precipitate osmotic diuresis and dehydration.
• Allergic responses ranging from skin rash or urticaria to severe anaphylactic shock.
• Significant electrolyte imbalances, such as hyponatremia, hyperkalemia, or shifts in calcium levels.

When prescribing Glucose B.Braun, clinicians should evaluate patient-specific factors and monitor for potential complications.

• Assess baseline blood glucose and adjust infusion rate to avoid hyperglycemia.
• Use caution in patients with diabetes mellitus, renal insufficiency, or congestive heart failure.
• Monitor fluid balance and signs of overload, especially during prolonged infusions.
• Verify compatibility with other intravenous solutions to prevent precipitation.
• Observe for signs of allergic reaction during the first administration.
• Adjust electrolyte supplementation as needed when large volumes are infused.

Glucose B.Braun may interact with other intravenous medications or conditions that affect glucose metabolism.

Avoid

• Concurrent administration with high‑dose insulin infusions without appropriate glucose monitoring.
• Mixing with calcium‑containing solutions that can precipitate when combined with phosphate buffers.

Use with caution

• Co‑administration with diuretics that may alter electrolyte status; monitor sodium and potassium levels.
• Use alongside beta‑blockers, which can mask symptoms of hypoglycemia.
• Infusion in patients receiving total parenteral nutrition containing other carbohydrate sources; adjust total glucose load.
• Administration with glucocorticoids, which can raise blood glucose, requires closer monitoring.